HEMA rodak's chapter quizzes Flashcards
(91 cards)
What is the most common clinical application of flow
cytometry?
a. Diagnosis of platelet disorders
b. Detection of fetomaternal hemorrhage
c. Diagnosis of leukemias and lymphomas
d. Differentiation of anemias
c. Diagnosis of leukemias and lymphomas
Which of the following is true of CD45 antigen?
a. It is present on every cell subpopulation in the bone marrow.
b. It is expressed on all hematopoietic cells, with the exception of megakaryocytes and late erythroid precursors.
c. It is not measured routinely in flow cytometry.
d. It may be present on nonhematopoietic cells.
b. It is expressed on all hematopoietic cells, with the exception of megakaryocytes and late erythroid precursors.
Erythroid precursors are characterized by the expression of:
a. CD71
b. CD20
c. CD61
d. CD3
a. CD71
Antigens expressed by B-LL include:
a. CD3, CD4, and CD8
b. CD19, CD34, and CD10
c. There are no antigens specific for B-LL.
d. Myeloperoxidase
b. CD19, CD34, and CD10
Which of the following is true of flow cytometric gating?
a. It is best defined as selection of a target population for flow cytometric analysis.
b. It can be done only at the time of data acquisition.
c. It can be done only at the time of final analysis and interpretation of
flow cytometric data.
d. It is accomplished by adjusting flow rate.
a. It is best defined as selection of a target population for flow cytometric analysis.
Collection of ungated events:
a. Facilitates comprehensive analysis of all cells
b. Does not help in detection of unexpected abnormal populations
c. Allows the collection of data on a large number of rare cells
d. Is used for leukemia diagnosis only
a. Facilitates comprehensive analysis of all cells
Mycosis fungoides is characterized by:
a. Loss of certain antigens compared with the normal T cell population
b. Polyclonal T cell receptor
c. Immunophenotype indistinguishable from that of normal T cells
d. Expression of CD3 and CD8 antigens
a. Loss of certain antigens compared with the normal T cell population
Mature granulocytes show the expression of:
a. CD15, CD33, and CD34
b. CD15, CD33, and CD41
c. CD15, CD33, and CD13
d. CD15, CD33, and CD7
c. CD15, CD33, and CD13
During the initial evaluation of flow cytometric data, cell size,
cytoplasmic complexity, and expression of CD45 antigen are used
to define cell subpopulations. Which of the following parameters
defines cytoplasmic complexity/ granularity?
a. SS
b. FS
c. CD45
d. HLA-DR
a. SS
The most important feature of the mature neoplastic B cell
population is:
a. The presence of a specific immunophenotype with expression of
CD19 antigen
b. A clonal light chain expression (i.e., exclusively k- or l-positive population)
c. A clonal T cell receptor expression
d. Aberrant expression of CD5 antigen on CD19+ cells
b. A clonal light chain expression (i.e., exclusively k- or l-positive population)
Lymphomas differ from leukemia in that they are:
a. Solid tumors
b. Not considered systemic disease
c. Never found in peripheral blood
d. Do not originate from hematopoietic cells
a. Solid tumors
Which one of the following viruses is known to cause
lymphoid neoplasms in humans?
a. HIV-1
b. HTLV-1
c. Hepatitis B
d. Parvovirus B
b. HTLV-1
Loss-of-function of tumor suppressor genes increases the
risk of hematologic neoplasms by:
a. Suppressing cell division
b. Activating tyrosine kinases which promote proliferation
c. Promoting excessive apoptosis of hematopoietic cells
d. Allowing cells with damaged DNA to progress through the cell cycle
d. Allowing cells with damaged DNA to progress through the cell cycle
Oncogenes are said to act in a dominant fashion because:
a. Leukemia is a dominating disease that is systemic
b. The oncogene product is a gain-of-function mutation
c. A mutation in only one allele is sufficient to promote a malignant phenotype
d. They are inherited by autosomal dominant transmission
c. A mutation in only one allele is sufficient to promote a malignant phenotype
Which one of the following is NOT one of the cellular
abnormalities produced by oncogenes:
a. Constitutive activation of a growth factor receptor
b. Constitutive activation of a signaling protein
c. Acceleration of DNA catabolism
d. Dysregulation of apoptosis
c. Acceleration of DNA catabolism
Which one of the following is an example of a tumor suppressor gene?
a. ABL1
b. RARA
c. TP53
d. JAK2
c. TP53
G-CSF is provided as supportive treatment during leukemia treatment regimens to:
a. Suppress GVHD
b. Overcome anorexia
c. Prevent anemia
d. Reduce the risk of infection
d. Reduce the risk of infection
Imatinib is an example of what type of leukemia treatment?
a. Supportive care
b. Chemotherapy
c. Bone marrow conditioning agent
d. Targeted therapy
d. Targeted therapy
Which one of the following is FALSE about epigenetic mechanisms?
a. Epigenetic mechanisms control how genes are expressed and silenced
b. Micro RNAs can bind to specific mRNAs and block their translation
c. Hypermethylation of CpG islands in gene promoters result in their overactivation
d. Histone deacetylases keep chromatin of target genes in a closed inactive state.
c. Hypermethylation of CpG islands in gene promoters result in their overactivation
Which one of the following is NOT a source of hematopoietic
stem cells for transplantation:
a. Spleen
b. Bone marrow
c. Peripheral blood
d. Umbilical cord blood
a. Spleen
MDS are most common in which age group?
a. 2 to 10 years
b. 15 to 20 years
c. 25 to 40 years
d. Older than 50 years
d. Older than 50 years
What is a major indication of MDS in the peripheral blood and bone marrow?
a. Dyspoiesis
b. Leukocytosis with left shift
c. Normal bone marrow with abnormal peripheral blood features
d. Thrombocytosis
a. Dyspoiesis
An alert hematologist should recognize all of the following peripheral blood abnormalities as diagnostic clues in MDS
EXCEPT:
a. Oval macrocytes
b. Target cells
c. Agranular neutrophils
d. Circulating micromegakaryocytes
b. Target cells
For an erythroid precursor to be considered a ring sideroblast, the iron-laden mitochondria must encircle how much of the nucleus?
a. One-quarter
b. One-third
c. Two-thirds
d. Entire nucleus
b. One-third